Specialties: Oncology

ClinicalInterests: Lymphoma

Education:

2003.9 - 2008.6 Bachelor degree in Clinical Medicine,Medical College of Guangdong Province, Zhanjiang, China

Publications:

1           Chen C^#, Liu S^#, Jiang X^#, Huang L^#, Chen F,Wei X, Guo H, Shao Y, Li Y^*, Li W^*. Tumormutation burden estimated by a 69-gene-panel is associated with overallsurvival in patients with diffuse large B-cell lymphoma. Exp Hematol Oncol.2021;10(1):20.

2            Chen F, Pang D, Guo H, Ou Q,Wu X, Jiang X, Wei X, Liu S,Huang L, Liang Z, Zhou D, Li W. Clinical outcomes of newly diagnosed primaryCNS lymphoma treated with ibrutinib-based combination therapy: A real-worldexperience of off-label ibrutinib use. Cancer Med. 2020;9(22):8676-8684.

3            Chen F, Pang D, Guo H, JiangX, Liu S, Huang L, Wei X, LiangZ, Wang X, Li W. Clinicopathological Characteristics and Mutational Profilingof Adult T-Cell Lymphoblastic Lymphoma in a Chinese Population. Cancer ManagRes. 2020 ;12:3003-3012.

4            Chen F, Guo H, Mao C, JiangX, Liu S, Huang L, Wei X, LiangZ, Zhou D, Li W. Unusual Relapse of Primary Central Nervous System LymphomaBoth Inside and Outside Central Nervous System in Patient withVentriculoperitoneal Shunt. World Neurosurg. 2019;127:625-628.

5           Mao C^#, Chen F^#, Li Y^#, Jiang X, Liu S, Guo H, Huang L,Wei X, Liang Z, Li W^*, Tang K^*.Characteristics and Outcomes of Primary Central Nervous System Lymphoma: ARetrospective Study of 91 Cases in a Chinese Population. World Neurosurg. 2019;123:e15-e24.

6           Huang L, Zhang F, Zeng J, Guo H,Liu S, Wei X, Chen F, Jiang X,Liang Z, Liu Y, Li W. ALK expression plays different roles in anaplasticlarge-cell lymphomas and outcome of crizotinib use in relapsed/refractory ALK+patients in a Chinese population. Ann Hematol. 2018;97(1):149-159.